In the September 2019 issue of Hepatology Communications, in the article titled “A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice,” (volume 3, pages 1221‐1234; doi: https://doi.org/10.1002/hep4.1405), by Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, and Ira Tabas, the nucleotide sequences for siTaz‐1 and ‐2 in Table 1 were incorrect. The correct table is displayed below.
Table 1.
Sequences of siTAZ‐1 and siTAZ‐2
| siRNA | Strand Direction | Sense Strand* | Antisense Strand* |
|---|---|---|---|
| siTAZ‐1 | 5′ → 3′ | cscsaGcCgAaUcUcGcAaUgAaUs(GalNAc3) | AsUsuCaUuGcGaGaUuCgGcsdTsdT |
| siTAZ‐2 | 5′ → 3′ | cscsaGgAuUaGgAuGcGuCaAgAs(GalNAc3) | UsCsuUgAcGcAuCcUaAuCcsdTsdT |
Small letters (a, c, g, u), 2′ O‐methyl oligo modification; capital letters, 2′‐F modification; s, phosphorothioate; (GalNAc3), trivalent GalNAc cluster.
We apologize for this mistake.